Gastrointestinal Cancer
News
‘Meticulous’ surgical procedure best defense against rectal cancer recurrence
In the clinical experience of Dr. Ian C. Lavery, prevention efforts are the best defense against local recurrence of rectal cancer.
Conference Coverage
Tissue flap reconstruction associated with higher costs, postop complication risk
LOS ANGELES – The use of locoregional tissue flaps in combination with abdominoperineal resection was associated with higher rates of...
Conference Coverage
Preoperative chemotherapy improves survival in patients with large anorectal GIST
The size of anorectal gastrointestinal stroma tumors and preop chemotherapy are the most important determinants of survival following resection,...
News
MyPathway: Targeted therapies show promise in nonindicated tumors
Agents that target the HER2, BRAF, Hedgehog, or EGFR pathways show promise in nonindicated tumor types that harbor these molecular alterations,...
Conference Coverage
Liquid biopsies prove useful alternative to tissue biopsies
Liquid biopsy, the testing of the blood for circulating tumor DNA (ctDNA), identified cancer mutations useful as biomarkers – many associated with...
Conference Coverage
Anticlaudin antibody increases survival in advanced gastric cancer
Key clinical point: A novel monoclonal antibody in combination with chemotherapy increased overall and progression-free survival in advanced...
Video
VIDEO: Dr. Roy Herbst talks combinations, evolutions, and innovations in lung cancer
Conference Coverage
Neoadjuvant chemo found to benefit locally advanced colon cancer
Treatment with neoadjuvant chemotherapy leads to significant downstaging in a selected group of patients with advanced colon cancer, results from...
Video
VIDEO: Combination boosts survival for resected pancreatic cancer
News
Combination regimen will likely change standard of care for resected pancreatic cancer
Key clinical point: Adding capecitabine to adjuvant gemcitabine nets a survival benefit in pancreatic cancer, without added serious toxicity....
News
VIDEO: Asymptomatic pancreatic cysts rarely became malignant
Only 1% of adults with asymptomatic neoplastic pancreatic cysts developed invasive pancreatic adenocarcinoma after more than 5 years of follow-up...